outcomes.ai

About outcomes.ai

OutcomesAI is a Boston-based healthcare technology company, founded in 2024 by Kuldeep Singh Rajput, who previously founded Biofourmis. The company is focused on addressing the global nursing shortage and clinical burnout by augmenting, rather than replacing, nursing staff. This mission is informed by Rajput's previous experience in scaling healthcare companies.

The firm operates on a hybrid model, combining artificial intelligence with licensed nurses to enhance capacity and efficiency. Its primary clients are health systems, virtual care providers, and pharmaceutical companies. The business model centers on deploying its proprietary AI engine, Glia®, to automate routine administrative and clinical tasks, thereby freeing up nurses to concentrate on more complex patient care. This approach is designed to increase nursing capacity by three to five times and reduce operational costs by up to 50% compared to traditional outsourced triage services.

Glia® is an ensemble of Large Language Models (LLMs) and Large Multi-Modal Models (LMMs) purpose-built for nursing workflows. Its AI voice agents handle inbound and outbound patient calls, manage symptom collection, schedule appointments, coordinate follow-ups, and provide patient education in multiple languages. For situations requiring human judgment, the system facilitates a seamless escalation to licensed nurses who are equipped with AI-powered productivity tools like real-time scribing, automated documentation, and protocol guidance. The platform integrates with existing Electronic Health Record (EHR) systems to ensure streamlined workflows. In October 2025, OutcomesAI secured $10 million in seed funding led by Santé Ventures to accelerate its commercial expansion. The company launched the OutcomesAI Collaboratory in 2024, partnering with leading health systems to validate the safety and performance of its Glia engine.